Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease
Objective: To identify if the Montreal Cognitive Assessment (MoCA) is a sensible tool to differentiate cognitive impairment profiles between patients with Essential Tremor (ET) and…Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report
Objective: To relate visuo-perceptual performance with cognitive and genetic measures in Parkinson’s disease. Background: Dementia is a common occurrence in Parkinson’s disease (PD), affecting up…BODILY AND FACIAL EMOTION RECOGNITION IN PARKINSON´S DISEASE
Objective: The aim of the current study is to directly compare performance in recognition of facial and bodily emotions. Background: Patients with Parkinson´s disease (PD) show…Quantitative EEG measures reflect general cognitive status in Parkinson’s disease
Objective: To explore the utility of the quantitative electroencephalogram (EEG) as a potential biomarker of cognitive status in patients with Parkinson's disease (PD). Background: While…Cognitive Training in Parkinson’s Disease: Experience in a Rehabilitation Hospital from Brazil
Objective: To determine the impact of cognitive training (CT) on cognitive and quality of life measures in patients with Parkinson's Disease (PD). Background: PD is…Cognitive Processes That Indirectly Effect Olfactory Dysfunction in Parkinson’s Disease
Objective: Investigate cognitive mechanisms contributing to olfactory dysfunction in Parkinson’s disease. Background: Accurate early diagnosis of Parkinson’s disease is hampered by its long prodromal period…Primary disruption of the subsystems of the default mode network in drug-naïve Parkinson’s disease with mild cognitive impairments: a resting-state functional connectivity MRI study
Objective: To study changes in subsystems in drug-naïve Parkinson’s disease with mild cognitive impairments using resting-state functional connectivity MRI. Background: Mild cognitive impairment (MCI) is common…Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)
Objective: To align with regulators on the utility and development strategy of novel clinical outcome assessments for use in Huntington’s disease (HD) clinical trials. Background:…Efficacy of Motor Imagery Questionnaire-RS as a Diagnostic Tool in Rehabilitation of Movement Disorders
Objective: The present study attempts to establish the normative reference value for motor imagery and compare it with patients with movement disorders. Background: Motor imagery,…Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease
Objective: This research aimed to study the specific changes in cognitive event related potentials (ERP) in patients with different non-motor subtypes of Parkinson’s disease (PD).…
- « Previous Page
- 1
- …
- 57
- 58
- 59
- 60
- 61
- …
- 117
- Next Page »